A Preview Of Talis Biomedical's Earnings
Portfolio Pulse from Benzinga Insights
Talis Biomedical (NASDAQ:TLIS) is set to release its latest quarterly earnings report on August 10, 2023. Analysts estimate an earnings per share (EPS) of $-0.73. The company's past performance shows a trend of share price drops following earnings reports. Shares are currently trading at $7.57 and have fallen 37.09% over the last 52-week period.
August 09, 2023 | 4:02 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Talis Biomedical is expected to report an EPS of $-0.73. The company's shares have been on a downward trend, falling 37.09% over the past year. The trend may continue if the company fails to meet or exceed the estimated EPS.
Talis Biomedical's stock price has been on a downward trend over the past year. The upcoming earnings report, if it fails to meet or exceed the estimated EPS, could further depress the stock price. The company's historical performance shows a pattern of share price drops following earnings reports, which suggests that investors may have negative expectations.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100